Education
About Us
Working with TipRanks
Follow Us
Alzamend Neuro (ALZN)
NASDAQ:ALZN
Total Valuation
Alzamend Neuro has a market cap or net worth of $8.21M. The enterprise value is ―.
Market Cap$8.21M
Enterprise Value―
Share Statistics
Alzamend Neuro has 3,801,604 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,801,604
Owned by Insiders1.49%
Owned by Institutions2.40%
Financial Efficiency
Alzamend Neuro’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -113.32%.
Return on Equity (ROE)-1.14
Return on Assets (ROA)-0.98
Return on Invested Capital (ROIC)-113.32%
Return on Capital Employed (ROCE)-1.13
Revenue Per Employee0.00
Profits Per Employee-1.13M
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Alzamend Neuro is ―. Alzamend Neuro’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio0.67
Price to Fair Value0.67
Price to FCF-0.39
Price to Operating Cash Flow-1.33
PEG Ratio0.03
Income Statement
In the last 12 months, Alzamend Neuro had revenue of 0.00 and earned -4.51M in profits. Earnings per share was -11.32.
Revenue0.00
Gross Profit-50.74K
Operating Income-4.50M
Pretax Income-4.51M
Net Income-4.51M
EBITDA-4.45M
Earnings Per Share (EPS)-11.32
Cash Flow
In the last 12 months, operating cash flow was -5.65M and capital expenditures -210.00K, giving a free cash flow of -5.86M billion.
Operating Cash Flow-5.65M
Free Cash Flow-5.86M
Free Cash Flow per Share-1.54
Dividends & Yields
Alzamend Neuro pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.62
52-Week Price Change-80.89%
50-Day Moving Average2.29
200-Day Moving Average3.75
Relative Strength Index (RSI)46.24
Average Volume (3m)146.22K
Important Dates
Alzamend Neuro upcoming earnings date is Mar 16, 2023, TBA (Confirmed).
Last Earnings DateMar 15, 2022
Next Earnings DateMar 16, 2023
Ex-Dividend Date―
Financial Position
Alzamend Neuro as a current ratio of 6.58, with Debt / Equity ratio of 0.00%
Current Ratio6.58
Quick Ratio6.58
Debt to Market Cap0.00
Net Debt to EBITDA0.89
Interest Coverage Ratio-249.42
Taxes
In the past 12 months, Alzamend Neuro has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Alzamend Neuro EV to EBITDA ratio is 0.29, with an EV/FCF ratio of 0.19.
EV to Sales0.00
EV to EBITDA0.29
EV to Free Cash Flow0.19
EV to Operating Cash Flow0.19
Balance Sheet
Alzamend Neuro has $4.45M in cash and marketable securities with $0.00 in debt, giving a net cash position of $4.45M billion.
Cash & Marketable Securities$4.45M
Total Debt$0.00
Net Cash$4.45M
Net Cash Per Share$1.17
Tangible Book Value Per Share$8.80
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Alzamend Neuro is $42.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$42.00
Price Target Upside1853.49% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―